Atlas Trials

A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis

Clinical trial NCT05951816 · RECRUITING

Trial details

NCT number
NCT05951816
Sponsor
University of Tennessee Graduate School of Medicine
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Systemic Amyloidosis
Start date
2023-09-18
Primary completion
2026-12-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.